CRY1
Cryptochrome-1
Also known as: CRY1_HUMAN, PHLL1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q16526
- Gene
- CRY1
- Ensembl
- ENSG00000008405
- Chromosome
- 12
- Canonical length
- 586 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear membrane,Microtubules
OverviewNCBI Gene
This gene encodes a flavin adenine dinucleotide-binding protein that is a key component of the circadian core oscillator complex, which regulates the circadian clock. This gene is upregulated by CLOCK/ARNTL heterodimers but then represses this upregulation in a feedback loop using PER/CRY heterodimers to interact with CLOCK/ARNTL. Polymorphisms in this gene have been associated with altered sleep patterns. The encoded protein is widely conserved across plants and animals. Loss of the related gene in mouse results in a shortened circadian cycle in complete darkness. [provided by RefSeq, Jan 2014]
Canonical amino-acid sequenceUniProt
586 residues, UniProt reviewed canonical sequence.
>Q16526|CRY1
1 MGVNAVHWFR KGLRLHDNPA LKECIQGADT IRCVYILDPW FAGSSNVGIN RWRFLLQCLE
61 DLDANLRKLN SRLFVIRGQP ADVFPRLFKE WNITKLSIEY DSEPFGKERD AAIKKLATEA
121 GVEVIVRISH TLYDLDKIIE LNGGQPPLTY KRFQTLISKM EPLEIPVETI TSEVIEKCTT
181 PLSDDHDEKY GVPSLEELGF DTDGLSSAVW PGGETEALTR LERHLERKAW VANFERPRMN
241 ANSLLASPTG LSPYLRFGCL SCRLFYFKLT DLYKKVKKNS SPPLSLYGQL LWREFFYTAA
301 TNNPRFDKME GNPICVQIPW DKNPEALAKW AEGRTGFPWI DAIMTQLRQE GWIHHLARHA
361 VACFLTRGDL WISWEEGMKV FEELLLDADW SINAGSWMWL SCSSFFQQFF HCYCPVGFGR
421 RTDPNGDYIR RYLPVLRGFP AKYIYDPWNA PEGIQKVAKC LIGVNYPKPM VNHAEASRLN
481 IERMKQIYQQ LSRYRGLGLL ASVPSNPNGN GGFMGYSAEN IPGCSSSGSC SQGSGILHYA
541 HGDSQQTHLL KQGRSSMGTG LSGGKRPSQE EDTQSIGPKV QRQSTNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CRY1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 35 nTPM
Expression across tissuesHPA
Tissue
- testis: 35 nTPM
- cerebellum: 24 nTPM
- lung: 20 nTPM
- retina: 20 nTPM
- thymus: 18 nTPM
- choroid plexus: 18 nTPM
Single-cell type
- epicardial cells: 414 nCPM
- endometrial stromal cells: 413 nCPM
- innate lymphoid cells: 407 nCPM
- salivary myoepithelial cells: 396 nCPM
- salivary acinar cells: 396 nCPM
- breast secretory cells: 353 nCPM
Immune cell
- MAIT T-cell: 16 nTPM
- T-reg: 14 nTPM
- gdT-cell: 13 nTPM
- basophil: 12 nTPM
- memory CD4 T-cell: 9.6 nTPM
- non-classical monocyte: 9 nTPM
Brain region
- choroid plexus: 28 nTPM
- cerebellum: 27 nTPM
- white matter: 19 nTPM
- midbrain: 14 nTPM
- thalamus: 14 nTPM
- medulla oblongata: 14 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CRY1.
Disease | AllUniProt
Conditions CRY1 is implicated in, by any mechanism.
- Delayed sleep phase syndrome (DSPS) MIM:614163
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.81
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.61
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- blue light signaling pathway
- circadian regulation of gene expression
- circadian rhythm
- entrainment of circadian clock by photoperiod
- gluconeogenesis
- glucose homeostasis
- lipid storage
- negative regulation of circadian rhythm
- negative regulation of DNA-templated transcription
- negative regulation of G protein-coupled receptor signaling pathway
- negative regulation of glucocorticoid secretion
- negative regulation of gluconeogenesis
- negative regulation of nuclear receptor-mediated glucocorticoid signaling pathway
- negative regulation of protein ubiquitination
- negative regulation of transcription by RNA polymerase II
- positive regulation of gluconeogenesis
- positive regulation of protein ubiquitination
- regulation of circadian rhythm
- regulation of DNA damage checkpoint
- response to activity
- response to glucagon
- response to insulin
- response to light stimulus
- signal transduction in response to DNA damage
Molecular functions
- blue light photoreceptor activity
- DNA binding
- double-stranded DNA binding
- E-box binding
- FAD binding
- histone deacetylase binding
- nuclear receptor binding
- phosphatase binding
- protein kinase binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Cryptochrome/DNA photolyase class 1
- Cryptochrome/DNA photolyase, FAD-binding domain
- DNA photolyase, N-terminal
- Rossmann-like alpha/beta/alpha sandwich fold
- Cryptochrome/DNA photolyase, FAD-binding domain-like superfamily
- Cryptochrome/photolyase, N-terminal domain superfamily
- DNA photolyase
- FAD binding domain of DNA photolyase
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CRY1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CRY1 as an antibody target. Whether an autoantibody or antibody against CRY1 could matter depends on whether native CRY1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CRY1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CRY1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...